Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: ABVC, Akeso, Amarin, Ascletis, Astrazeneca, Beigene, Canbridge, Daiichi Sankyo, Everest Medicines, Gmax, Junshi, Novavax, Nuance.